From: Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma
Sample | Tissue | Appearance | Age/gender1 | Clinical Diagnosis |
---|---|---|---|---|
BRN0 | Brain | Normal | 26/M | Normal |
BRC0 | Brain | Tumor | 40/M | Astrocytoma |
BEN0–4 | Breast | Normal | 82/F. 45/F. 56/F. 64/F. 76/F | Normal |
BEC0 | Breast | Tumor | 47/F | Medullary Carcinoma, Well Differentiated |
BEC1 | Breast | Tumor | 40/F | Invasive Lobular Carcinoma |
BEC2 | Breast | Tumor | 42/F | Adenocarcinoma, Moderately Differentiated |
BEC3 | Breast | Tumor | 42/F | Fibroadenoma |
BEC4 | Breast | Tumor | 50/F | Infiltrative Ductal Carcinoma |
CLN0 | Colon | Normal | 60/F | Normal |
CLC0 | Colon | Tumor | 48/M | Adenocarcinoma, Well Differentiated |
KDN0 | Kidney | Normal | 83/F | Normal |
KDC0 | kidney | Tumor | 43/F | Granular Cell Carcinoma |
LVN0 | Liver | Normal | 30/M | Normal |
LVC0 | Liver | Tumor | 65/M | Hepatic Cellular Carcinoma |
LUN0–4 | Lung | Normal | 24/F. 26/M. 66/M. 71/M.76/F | Normal |
LUC0 | Lung | Tumor | 72/M | Squamous Cell Carcinoma |
LUC1 | Lung | Tumor | 33/M | Squamous Cell Carcinoma, Moderately Differenciated |
LUC2 | Lung | Tumor | 51/F | Adenocarcinoma, Moderately Differentiated |
LUC3 | Lung | Tumor | 58/M | Squamous Cell Carcinoma, Moderately Differenciated |
LUC4 | Lung | Tumor | 61/M | Adenocarcinoma |
OVN0–4 | Ovary | Normal | 74/F. 37/F. 62/F.69F. N/A/F | Normal |
OVC0 | Ovary | Tumor | 51/F | Cystoadenocarcinoma |
OVC1 | Ovary | Tumor | 42/F | Granular Cell Tumor |
OVC2 | Ovary | Tumor | 51/F | Cystoadenoma |
OVC3 | Ovary | Tumor | 57/F | Leiomyosarcoma, Well Differentiated |
OVC4 | Ovary | Tumor | Adult/F | Clear Cell Adenocarcinoma |
BE1N | Breast | Adjacent Normal | 70/F, same patient | Normal |
BE1P | Breast | Primary Tumor | Â | Invasive Ductal Carcinoma |
BE2P | Breast | Primary Tumor | 59/F, same patient | Breast Carcinoma |
BE2M | Breast | Metastatic Tumor | Â | Breast Tumor Metastasized to Lung |
CL1N | Colon | Adjacent Normal | 62/F. same patient | Normal |
CL1P | Colon | Primary Tumor | Â | Adenocarcinoma |
CL2P | Colon | Primary Tumor | 66/F. same patient | Adenocarcinoma |
CL2M | Colon | Metastatic Tumor | Â | Colon Tumor Metastasized to Lymph Node |
LU1N | Lung | Adjacent Normal | 46/M, same patient | Normal |
LU1P | Lung | Primary Tumor | Â | Squamous Cell Carcinoma |
LU2P | Lung | Primary Tumor | 75/M. same patient | Squamous Cell Carcinoma |
LU2M | Lung | Metastatic Tumor | Â | Lung Tumor Metastasized to Lymph Node |